TCM
TPST icon

Tang Capital Management’s Tempest Therapeutics TPST Stock Holding History

Tang Capital Management’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-138,962
Closed -$945K – 208
2025
Q2 		$945K Buy
+138,962
New +$988K 0.05% 159

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Tang Capital Management's TPST Position: Q3 2025 in Review

Tang Capital Management sold out of Tempest Therapeutics (TPST) in Q3 2025, closing a stake of 138,962 shares — an estimated $945K sold.

Tang Capital Management first reported a position in TPST in Q2 2025 and held it in 1 quarter. The position peaked at $945K in Q2 2025. 17 funds tracked by Wall St. Rank hold TPST as of Q3 2025.

  • Tang Capital Management reported no remaining Tempest Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Tang Capital Management sold 138,962 Tempest Therapeutics shares in Q3 2025, an estimated $945K.
  • Tang Capital Management first reported a position in Tempest Therapeutics in Q2 2025 and held it in 1 quarter.
  • Tang Capital Management's Tempest Therapeutics position peaked at $945K in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2025.

Based on Tang Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.